Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00028795
Other study ID # ACNS0126
Secondary ID COG-ACNS0126CDR0
Status Completed
Phase Phase 2
First received January 4, 2002
Last updated February 19, 2014
Start date December 2002
Est. completion date March 2012

Study information

Verified date February 2014
Source Children's Oncology Group
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Giving chemotherapy together with radiation therapy may kill more tumor cells.

PURPOSE: This phase II trial is studying how well giving chemotherapy together with radiation therapy after surgery followed by chemotherapy alone works in children with newly diagnosed astrocytoma, glioblastoma multiforme, gliosarcoma, or diffuse intrinsic pontine glioma.


Description:

OBJECTIVES:

- Compare the event-free survival of patients with newly diagnosed anaplastic astrocytoma, glioblastoma multiforme, gliosarcoma, or diffuse intrinsic pontine glioma (DIPG) treated with adjuvant temozolomide administered concurrently with postoperative radiotherapy and then alone as maintenance therapy vs historical control cohorts treated in prior Pediatric Oncology Group and Children's Cancer Group studies.

- Determine the toxicity of this regimen in these patients.

- Determine the efficacy of this regimen in patients with DIPG.

- Determine the toxicity of this regimen in patients with DIPG.

OUTLINE: This is a multicenter study.

- Adjuvant chemoradiotherapy: Beginning within 6 weeks after surgical resection or diagnosis*, patients without gross residual disease undergo cranial irradiation 5 days a week for 6 weeks. Beginning within 6 weeks after surgical resection, patients with gross residual disease undergo radiotherapy as above followed by boost radiotherapy for 1 week. All patients receive oral temozolomide once daily beginning within 5 days after initiation of radiotherapy and continuing for a total of 6 weeks in the absence of disease progression or unacceptable toxicity.

- Adjuvant maintenance therapy: Beginning 4 weeks after completion of adjuvant chemoradiotherapy, patients receive oral temozolomide on days 1-5. Treatment repeats every 28 days for a total of 10 courses in the absence of disease progression or unacceptable toxicity.

NOTE: *For patients with diffuse intrinsic pontine glioma only

Patients are followed every 3-6 months for 4 years and then annually thereafter.

PROJECTED ACCRUAL: A total of 50-60 patients will be accrued for this study within 12-14 months.


Recruitment information / eligibility

Status Completed
Enrollment 170
Est. completion date March 2012
Est. primary completion date September 2007
Accepts healthy volunteers No
Gender Both
Age group 3 Years to 21 Years
Eligibility DISEASE CHARACTERISTICS:

- Histologically confirmed newly diagnosed CNS tumor of the following types:

- High grade glioma (HGG) of one of the following histologies:

- Anaplastic astrocytoma (grade III)

- Glioblastoma multiforme (grade IV)

- Gliosarcoma

- Primary spinal cord malignant glioma

- Diffuse intrinsic pontine glioma (DIPG)

- Diagnosed by gadolinium-enhanced MRI

- At least 2/3 of tumor situated in the pons AND tumor clearly originated in the pons

- No diffuse leptomeningeal disease

- No tumors with features not typical of diffuse intrinsic brainstem glioma, including any of the following:

- Dorsally exophytic brainstem glioma

- Cervico-medullary junction tumor

- Focal low-grade glioma of the midbrain or brainstem

- No diffuse brainstem enlargement due to neurofibromatosis

- No primary brain stem malignant glioma

- No M+ disease (CSF positive for tumor or metastatic disease)

- Must begin study radiotherapy within 6 weeks after surgical resection (for HGG patients) or diagnosis (for DIPG patients)

PATIENT CHARACTERISTICS:

Age:

- 3 to 21

Performance status:

- Karnofsky 50-100% OR

- Lansky 50-100%

Life expectancy:

- At least 2 months

Hematopoietic:

- Absolute neutrophil count at least 1,000/mm^3

- Platelet count at least 100,000/mm^3*

- Hemoglobin at least 10.0 g/dL* NOTE: *Transfusion independent

Hepatic:

- Bilirubin no greater than 1.5 times upper limit of normal (ULN)

- SGOT or SGPT less than 2.5 times ULN

Renal:

- Creatinine no greater than 1.5 times ULN

Other:

- No other concurrent malignancy

- Concurrent seizure disorder allowed if well controlled on anticonvulsants

- Not pregnant or nursing

- Negative pregnancy test

- Fertile patients must use effective contraception during and for 2 months after completion of study treatment

PRIOR CONCURRENT THERAPY:

Biologic:

- No concurrent routine cytokine support

Chemotherapy:

- Not specified

Endocrine therapy:

- No concurrent corticosteroids except for increased intracranial pressure in patients with CNS tumors

Radiotherapy:

- See Disease Characteristics

Surgery:

- See Disease Characteristics

Other:

- No prior therapy for HGG or DIPG

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
temozolomide

Procedure:
adjuvant therapy

Radiation:
radiation therapy


Locations

Country Name City State
Australia Royal Children's Hospital Brisbane Queensland
Australia Women's and Children's Hospital North Adelaide South Australia
Australia Royal Children's Hospital Parkville Victoria
Australia Princess Margaret Hospital for Children Perth Western Australia
Australia Sydney Children's Hospital Randwick New South Wales
Australia Children's Hospital at Westmead Westmead New South Wales
Canada Alberta Children's Hospital Calgary Alberta
Canada Cross Cancer Institute at University of Alberta Edmonton Alberta
Canada IWK Health Centre Halifax Nova Scotia
Canada McMaster Children's Hospital at Hamilton Health Sciences Hamilton Ontario
Canada Children's Hospital of Western Ontario London Ontario
Canada Hopital Sainte Justine Montreal Quebec
Canada Montreal Children's Hospital at McGill University Health Center Montreal Quebec
Canada Children's Hospital of Eastern Ontario Ottawa Ontario
Canada Allan Blair Cancer Centre at Pasqua Hospital Regina Saskatchewan
Canada Centre de Recherche du Centre Hospitalier de l'Universite Laval Sainte Foy Quebec
Canada Saskatoon Cancer Centre Saskatoon Saskatchewan
Canada Janeway Children's Health and Rehabilitation Centre St. John's Newfoundland and Labrador
Canada Hospital for Sick Children Toronto Ontario
Canada British Columbia Children's Hospital Vancouver British Columbia
Canada CancerCare Manitoba Winnipeg Manitoba
Netherlands University Medical Center Groningen Groningen
New Zealand Starship Children's Health Auckland
Puerto Rico Puerto Rico Cancer Center at University of Puerto Rico - Medical Sciences Campus San Juan
Puerto Rico San Jorge Children's Hospital Santurce
Switzerland Swiss Pediatric Oncology Group Bern Bern
Switzerland Swiss Pediatric Oncology Group Geneva Geneva
Switzerland Swiss Pediatric Oncology Group Lausanne Lausanne
United States Children's Hospital Medical Center of Akron Akron Ohio
United States Children's Hospital at Albany Medical Center Albany New York
United States University of New Mexico Cancer Research and Treatment Center Albuquerque New Mexico
United States Texas Tech University Health Sciences Center School of Medicine Amarillo Texas
United States University of Michigan Comprehensive Cancer Center Ann Arbor Michigan
United States Mission Hospitals - Memorial Campus Asheville North Carolina
United States AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish Rite Campus Atlanta Georgia
United States MBCCOP-Medical College of Georgia Cancer Center Augusta Georgia
United States Children's Hospital of Austin Austin Texas
United States Alvin and Lois Lapidus Cancer Institute at Sinai Hospital Baltimore Maryland
United States Greenebaum Cancer Center at University of Maryland Medical Center Baltimore Maryland
United States Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland
United States Pediatric Specialty Clinic at Eastern Maine Medical Center Bangor Maine
United States Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham Alabama
United States St. Luke's Mountain States Tumor Institute - Boise Boise Idaho
United States Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston Massachusetts
United States Floating Hospital for Children Boston Massachusetts
United States Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx New York
United States Brookdale University Hospital and Medical Center Brooklyn New York
United States Brooklyn Hospital Center Brooklyn New York
United States Comprehensive Cancer Center at Maimonides Medical Center Brooklyn New York
United States SUNY Downstate Medical Center Brooklyn New York
United States Vermont Cancer Center at University of Vermont Burlington Vermont
United States Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina
United States Hollings Cancer Center at Medical University of South Carolina Charleston South Carolina
United States West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division Charleston West Virginia
United States Blumenthal Cancer Center at Carolinas Medical Center Charlotte North Carolina
United States Presbyterian Cancer Center at Presbyterian Hospital Charlotte North Carolina
United States University of Virginia Cancer Center Charlottesville Virginia
United States Children's Memorial Hospital - Chicago Chicago Illinois
United States Rush University Medical Center Chicago Illinois
United States University of Chicago Cancer Research Center Chicago Illinois
United States University of Illinois Medical Center Chicago Illinois
United States Cincinnati Children's Hospital Medical Center Cincinnati Ohio
United States Cleveland Clinic Taussig Cancer Center Cleveland Ohio
United States Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University Cleveland Ohio
United States Palmetto Health South Carolina Cancer Center Columbia South Carolina
United States University of Missouri - Columbia Columbia Missouri
United States Columbus Children's Hospital Columbus Ohio
United States Medical City Dallas Hospital Dallas Texas
United States Simmons Cancer Center at University of Texas Southwestern Medical Center at Dallas Dallas Texas
United States Geisinger Medical Center Danville Pennsylvania
United States Children's Medical Center - Dayton Dayton Ohio
United States Children's Hospital Cancer Center Denver Colorado
United States Presbyterian - St. Luke's Medical Center Denver Colorado
United States Blank Children's Hospital Des Moines Iowa
United States Children's Hospital of Michigan Detroit Michigan
United States Van Elslander Cancer Center at St. John Hospital and Medical Center Detroit Michigan
United States Southern California Permanente Medical Group Downey California
United States City of Hope Comprehensive Cancer Center Duarte California
United States St. Mary's - Duluth Clinic Cancer Center Duluth Minnesota
United States Duke Comprehensive Cancer Center Durham North Carolina
United States INOVA Fairfax Hospital Falls Church Virginia
United States Dakota Cancer Institute at Innovis Health - Dakota Clinic Fargo North Dakota
United States Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center Farmington Connecticut
United States Hurley Medical Center Flint Michigan
United States Broward General Medical Center Fort Lauderdale Florida
United States Children's Hospital of Southwest Florida Fort Myers Florida
United States Cook Children's Medical Center - Fort Worth Fort Worth Texas
United States University of Florida Shands Cancer Center Gainesville Florida
United States University of Texas Medical Branch Galveston Texas
United States DeVos Children's Hospital Grand Rapids Michigan
United States Bellin Memorial Hospital Green Bay Wisconsin
United States CCOP - St. Vincent Hospital Cancer Center, Green Bay Green Bay Wisconsin
United States St. Vincent Hospital Green Bay Wisconsin
United States Children's Hospital of Greenville Hospital System Greenville South Carolina
United States Leo W. Jenkins Cancer Center at Pitt County Memorial Hospital Greenville North Carolina
United States Hackensack University Medical Center Hackensack New Jersey
United States Penn State Children's Hospital Hershey Pennsylvania
United States Joe DiMaggio Children's Hospital at Memorial Hollywood Florida
United States Cancer Research Center of Hawaii Honolulu Hawaii
United States Tripler Army Medical Center Honolulu Hawaii
United States Baylor College of Medicine Houston Texas
United States M.D. Anderson Cancer Center at University of Texas Houston Texas
United States Cabell Huntington Hospital Huntington West Virginia
United States Riley Children Cancer Center at Riley Hospital for Children Indianapolis Indiana
United States St. Vincent Hospitals and Health Care Centers Indianapolis Indiana
United States Holden Comprehensive Cancer Center at University of Iowa Iowa City Iowa
United States University of Mississippi Medical Center Jackson Mississippi
United States Nemours Children's Clinic Jacksonville Florida
United States East Tennessee State University Cancer Center at Johnson City Medical Center Johnson City Tennessee
United States Bronson Methodist Hospital Kalamazoo Michigan
United States Children's Mercy Hospital Kansas City Missouri
United States East Tennessee Children's Hospital Knoxville Tennessee
United States Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center La Crosse Wisconsin
United States Rebecca and John Moores UCSD Cancer Center La Jolla California
United States San Antonio Military Pediatric Cancer and Blood Disorders Center Lackland Air Force Base Texas
United States Breslin Cancer Center at Ingham Regional Medical Center Lansing Michigan
United States Nevada Cancer Research Foundation Las Vegas Nevada
United States Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon New Hampshire
United States Markey Cancer Center at University of Kentucky Chandler Medical Center Lexington Kentucky
United States Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock Arkansas
United States Loma Linda University Cancer Institute at Loma Linda University Medical Center Loma Linda California
United States Jonathan Jaques Children's Cancer Center at Miller Children's Hospital Long Beach California
United States Children's Hospital Los Angeles Los Angeles California
United States Jonsson Comprehensive Cancer Center at UCLA Los Angeles California
United States Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center Los Angeles California
United States Kosair Children's Hospital Louisville Kentucky
United States Covenant Children's Hospital Lubbock Texas
United States Medical Center of Central Georgia Macon Georgia
United States Children's Hospital Central California Madera California
United States University of Wisconsin Comprehensive Cancer Center Madison Wisconsin
United States CCOP - Marshfield Clinic Research Foundation Marshfield Wisconsin
United States Marshfield Clinic - Marshfield Center Marshfield Wisconsin
United States St. Jude Children's Research Hospital Memphis Tennessee
United States Baptist-South Miami Regional Cancer Program Miami Florida
United States Jackson Memorial Hospital Miami Florida
United States Miami Children's Hospital Miami Florida
United States Midwest Children's Cancer Center Milwaukee Wisconsin
United States Children's Hospitals and Clinics - Minneapolis/St. Paul Minneapolis Minnesota
United States University of South Alabama Cancer Research Institute Mobile Alabama
United States Mary Babb Randolph Cancer Center at West Virginia University Hospitals Morgantown West Virginia
United States Vanderbilt Children's Hospital Nashville Tennessee
United States Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick New Jersey
United States Yale Comprehensive Cancer Center New Haven Connecticut
United States Schneider Children's Hospital New Hyde Park New York
United States Children's Hospital of New Orleans New Orleans Louisiana
United States MBCCOP - LSU Health Sciences Center New Orleans Louisiana
United States Ochsner Cancer Institute at Ochsner Clinic Foundation New Orleans Louisiana
United States Tulane Cancer Center at Tulane University Hospital and Clinic New Orleans Louisiana
United States Herbert Irving Comprehensive Cancer Center at Columbia University New York New York
United States Memorial Sloan-Kettering Cancer Center New York New York
United States Mount Sinai Medical Center New York New York
United States New York Weill Cornell Cancer Center at Cornell University New York New York
United States Newark Beth Israel Medical Center Newark New Jersey
United States Children's Hospital of the King's Daughters Norfolk Virginia
United States Advocate Hope Children's Hospital Oak Lawn Illinois
United States Children's Hospital and Research Center at Oakland Oakland California
United States Children's Hospital at Oklahoma University Medical Center Oklahoma City Oklahoma
United States Children's Hospital of Omaha Omaha Nebraska
United States UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha Nebraska
United States Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange California
United States Children's Hospital of Orange County Orange California
United States Florida Hospital Cancer Institute Orlando Florida
United States Nemours Children's Clinic-Orlando Orlando Florida
United States Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto California
United States Lutheran General Cancer Care Center Park Ridge Illinois
United States St. Joseph's Hospital and Medical Center Paterson New Jersey
United States Sacred Heart Children's Hospital Pensacola Florida
United States Saint Jude Midwest Affiliate Peoria Illinois
United States Children's Hospital of Philadelphia Philadelphia Pennsylvania
United States St. Christopher's Hospital for Children Philadelphia Pennsylvania
United States Phoenix Children's Hospital Phoenix Arizona
United States Children's Hospital of Pittsburgh Pittsburgh Pennsylvania
United States CCOP - Columbia River Oncology Program Portland Oregon
United States Doernbecher Children's Hospital at Oregon Health & Science University Portland Oregon
United States Legacy Emanuel Hospital and Health Center & Children's Hospital Portland Oregon
United States Naval Medical Center - Portsmouth Portsmouth Virginia
United States Rhode Island Hospital Providence Rhode Island
United States Massey Cancer Center at Virginia Commonwealth University Richmond Virginia
United States Carilion Medical Center for Children at Roanoke Community Hospital Roanoke Virginia
United States James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester New York
United States Mayo Clinic Cancer Center Rochester Minnesota
United States William Beaumont Hospital - Royal Oak Campus Royal Oak Michigan
United States Kaiser Permanente Medical Center - Sacramento Sacramento California
United States Sutter Cancer Center Sacramento California
United States University of California Davis Cancer Center Sacramento California
United States Cardinal Glennon Children's Hospital Saint Louis Missouri
United States St. Louis Children's Hospital Saint Louis Missouri
United States Huntsman Cancer Institute at University of Utah Salt Lake City Utah
United States MBCCOP - South Texas Pediatrics San Antonio Texas
United States Methodist Cancer Center at Methodist Specialty and Transplant Hospital San Antonio Texas
United States University of Texas Health Science Center at San Antonio San Antonio Texas
United States Children's Hospital and Health Center - San Diego San Diego California
United States Kaiser Permanente Medical Center/Kaiser Foundation Hospital - San Diego San Diego California
United States UCSF Comprehensive Cancer Center San Francisco California
United States Santa Barbara Cottage Hospital Santa Barbara California
United States Kaiser Permanente Medical Center - Santa Clara Kiely Campus Santa Clara California
United States Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah Georgia
United States Maine Children's Cancer Program Scarborough Maine
United States Children's Hospital and Regional Medical Center - Seattle Seattle Washington
United States Fred Hutchinson Cancer Research Center Seattle Washington
United States Group Health Central Hospital Seattle Washington
United States Walter Reed Army Medical Center Silver Spring Maryland
United States Avera Cancer Institute Sioux Falls South Dakota
United States Sioux Valley Hospital and University of South Dakota Medical Center Sioux Falls South Dakota
United States Deaconess Medical Center Spokane Washington
United States Baystate Regional Cancer Program at D'Amour Center for Cancer Care Springfield Massachusetts
United States Southern Illinois University School of Medicine Springfield Illinois
United States All Children's Hospital St. Petersburg Florida
United States Long Island Cancer Center at Stony Brook University Hospital Stony Brook New York
United States Valerie Fund Children's Center at Atlantic Health Summit New Jersey
United States SUNY Upstate Medical University Hospital Syracuse New York
United States Madigan Army Medical Center Tacoma Washington
United States Mary Bridge Children's Hospital and Health Center - Tacoma Tacoma Washington
United States St. Joseph's Children's Hospital of Tampa Tampa Florida
United States CCOP - Scott and White Hospital Temple Texas
United States Center for Cancer Prevention and Care at Scott and White Clinic Temple Texas
United States St. Vincent Mercy Medical Center Toledo Ohio
United States Toledo Children's Hospital Toledo Ohio
United States General Robert Huyser Cancer Center at David Grant Medical Center Travis Air Force Base California
United States Arizona Cancer Center at University of Arizona Health Sciences Center Tucson Arizona
United States Natalie Warren Bryant Cancer Center at St. Francis Hospital Tulsa Oklahoma
United States New York Medical College Valhalla New York
United States Children's National Medical Center Washington District of Columbia
United States Lombardi Cancer Center at Georgetown University Medical Center Washington District of Columbia
United States Kaplan Cancer Center at St. Mary's Medical Center West Palm Beach Florida
United States Wesley Medical Center Wichita Kansas
United States Alfred I. duPont Hospital for Children Wilmington Delaware
United States Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina
United States UMASS Memorial Cancer Center - University Campus Worcester Massachusetts
United States Tod Children's Hospital - Forum Health Youngstown Ohio

Sponsors (2)

Lead Sponsor Collaborator
Children's Oncology Group National Cancer Institute (NCI)

Countries where clinical trial is conducted

United States,  Australia,  Canada,  Netherlands,  New Zealand,  Puerto Rico,  Switzerland, 

References & Publications (5)

Cohen KJ, Heideman RL, Zhou T, Holmes EJ, Lavey RS, Bouffet E, Pollack IF. Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group. Neuro Oncol. 2011 Apr;13(4):410-6. do — View Citation

Cohen KJ, Pollack IF, Zhou T, Buxton A, Holmes EJ, Burger PC, Brat DJ, Rosenblum MK, Hamilton RL, Lavey RS, Heideman RL. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol. 2011 Mar;13 — View Citation

Nicholson HS, Kretschmar CS, Krailo M, Bernstein M, Kadota R, Fort D, Friedman H, Harris MB, Tedeschi-Blok N, Mazewski C, Sato J, Reaman GH. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report f — View Citation

Pollack IF, Hamilton RL, Burger PC, Brat DJ, Rosenblum MK, Murdoch GH, Nikiforova MN, Holmes EJ, Zhou T, Cohen KJ, Jakacki RI; Children's Oncology Group. Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group. J Neurooncol. 2010 Sep;99(2):155-63. doi: 10.1007/s11060-010-0297-3. Epub 2010 Jul 4. — View Citation

Pollack IF, Hamilton RL, Sobol RW, Nikiforova MN, Nikiforov YE, Lyons-Weiler MA, LaFramboise WA, Burger PC, Brat DJ, Rosenblum MK, Gilles FH, Yates AJ, Zhou T, Cohen KJ, Finlay JL, Jakacki RI; Children's Oncology Group. Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2010 Dec 1;55(6):1066-71. doi: 10.1002/pbc.22634. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Improved outcome No
Primary Toxicity as assessed by NCI CTCAE v. 2.0 Yes
See also
  Status Clinical Trial Phase
Terminated NCT00788125 - Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Phase 1/Phase 2
Completed NCT00006080 - Fenretinide in Treating Patients With Recurrent Malignant Glioma Phase 2
Recruiting NCT00887146 - Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma Phase 3
Suspended NCT00935090 - 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer N/A
Completed NCT00621686 - Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme Phase 2
Completed NCT00112502 - Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme Phase 2
Terminated NCT00227032 - Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme Phase 1
Terminated NCT00243022 - Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme Phase 2
Active, not recruiting NCT00087815 - Hyperbaric Oxygen Therapy in Treating Patients With Radiation Necrosis of the Brain N/A
Active, not recruiting NCT00278278 - Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas Phase 3
Completed NCT00416819 - Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma N/A
Completed NCT00052286 - Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer N/A
Completed NCT00006093 - EMD 121974 in Treating Patients With Progressive or Recurrent Glioma Phase 1/Phase 2
Recruiting NCT00004129 - Phosphorus 32 in Treating Patients With Glioblastoma Multiforme Phase 1
Completed NCT00004212 - DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas Phase 1
Completed NCT00003417 - Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme Phase 1/Phase 2
Completed NCT00008008 - Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma Phase 2
Completed NCT00003484 - Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors Phase 1
Completed NCT00003020 - LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases Phase 1
Completed NCT00003173 - High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors Phase 2